149 related articles for article (PubMed ID: 34060965)
1. Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia.
Boulland ML; Vic S; Thonier F; Ganard M; Lamy T; Fest T; Guibert S; Pastoret C
Leuk Lymphoma; 2021 Nov; 62(11):2800-2803. PubMed ID: 34060965
[No Abstract] [Full Text] [Related]
2. Another step forward in the 20-year history of
Giudice ID; Foà R
Haematologica; 2019 Feb; 104(2):219-221. PubMed ID: 30705114
[No Abstract] [Full Text] [Related]
3. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
[TBL] [Abstract][Full Text] [Related]
4. Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.
Bourbon E; Chabane K; Mosnier I; Bouvard A; Thonier F; Ferrant E; Michallet AS; Poulain S; Hayette S; Sujobert P; Huet S
J Mol Diagn; 2023 May; 25(5):274-283. PubMed ID: 36773701
[TBL] [Abstract][Full Text] [Related]
5. Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Sandoval-Sus JD; Chavez JC; Dalia S; Naqvi SMH; Talati C; Nodzon L; Kharfan-Dabaja MA; Pinilla-Ibarz J
Leuk Lymphoma; 2018 Jan; 59(1):59-68. PubMed ID: 28641468
[TBL] [Abstract][Full Text] [Related]
6. Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia.
Huet S; Bouvard A; Ferrant E; Mosnier I; Chabane K; Salles G; Michallet AS; Hayette S; Sujobert P
Leukemia; 2020 Aug; 34(8):2257-2259. PubMed ID: 31996767
[No Abstract] [Full Text] [Related]
7. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
8. A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.
Best OG; Gardiner AC; Davis ZA; Tracy I; Ibbotson RE; Majid A; Dyer MJ; Oscier DG
Leukemia; 2009 Jan; 23(1):212-4. PubMed ID: 18818700
[No Abstract] [Full Text] [Related]
9. Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
Delgado J; Salaverria I; Baumann T; Martínez-Trillos A; Lee E; Jiménez L; Navarro A; Royo C; Santacruz R; López C; Payer AR; Colado E; González M; Armengol L; Colomer D; Pinyol M; Villamor N; Aymerich M; Carrió A; Costa D; Clot G; Giné E; López-Guillermo A; Campo E; Beà S
Haematologica; 2014 Nov; 99(11):e231-4. PubMed ID: 24997154
[No Abstract] [Full Text] [Related]
10. Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.
Rodríguez CM; Stanganelli C; Bussi C; Arroyo D; Sastre D; Heller V; Iribarren P; Slavutsky I
Leuk Lymphoma; 2018 May; 59(5):1239-1243. PubMed ID: 28868956
[No Abstract] [Full Text] [Related]
11. Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
Sheikholeslami MR; Ma W; Uyeji J; Tornyos K; Cone L; Mamus S; Albitar M
Br J Haematol; 2007 Nov; 139(3):507-9. PubMed ID: 17868045
[No Abstract] [Full Text] [Related]
12. Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?
Langerak AW; Davi F; Stamatopoulos K
Br J Haematol; 2020 Jun; 189(5):809-810. PubMed ID: 32002980
[No Abstract] [Full Text] [Related]
13. Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing.
Davi F; Langerak AW; de Septenville AL; Kolijn PM; Hengeveld PJ; Chatzidimitriou A; Bonfiglio S; Sutton LA; Rosenquist R; Ghia P; Stamatopoulos K;
Leukemia; 2020 Oct; 34(10):2545-2551. PubMed ID: 32561841
[TBL] [Abstract][Full Text] [Related]
14. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
15. Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia.
Hamblin TJ
Leuk Res; 2011 Nov; 35(11):1432-5. PubMed ID: 21840049
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in chronic lymphocytic leukemia.
Vyas N; Hassan A
Indian J Cancer; 2012; 49(1):137-43. PubMed ID: 22842181
[TBL] [Abstract][Full Text] [Related]
17. [Impact of immunoglobulin gene somatic high mutation on prognosis of the chronic lymphocytic leukemia].
Liu H; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1588-91. PubMed ID: 20030953
[TBL] [Abstract][Full Text] [Related]
18. IgVH mutations in patients with chronic lymphocytic leukemia.
Foà R
Haematologica; 2005 Apr; 90(4):434-5. PubMed ID: 15820928
[No Abstract] [Full Text] [Related]
19. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.
Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stilgenbauer S; Stevenson F; Davi F; Rosenquist R;
Leukemia; 2007 Jan; 21(1):1-3. PubMed ID: 17167526
[No Abstract] [Full Text] [Related]
20. Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
Bomben R; Dal Bo M; Zucchetto A; Zaina E; Nanni P; Sonego P; Del Poeta G; Degan M; Gattei V
Leukemia; 2005 Aug; 19(8):1490-2. PubMed ID: 15944717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
